Literature DB >> 3545350

Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.

S Barasi, M M Ben-Sreti, A L Clatworthy, K N Duggal, J P Gonzalez, J Robertson, K F Rooney, R D Sewell.   

Abstract

Nociceptive tail flick latencies (TFL) were recorded in response to noxious thermal stimuli applied to lightly anaesthetized rats. The effects of intrathecally administered dopamine receptor agonists alone and combined with dopamine receptor antagonists were examined upon the TFL. Experiments were repeated on animals made supersensitive to dopamine following withdrawal from 28 day administration of haloperidol. In untreated animals the D2-receptor agonist LY 171555 and apomorphine produced an increase in TFL. In contrast, the Di-receptor agonist SKF 38393 had no significant effect on TFL. TFL. Following haloperidol-induced dopamine-supersensitivity, SKF 38393 produced an increase in TFL. In contrast, LY171555 and apomorphine had minimal effects on TFL in this preparation. In animals not treated with haloperidol, the dopamine receptor antagonists SCH 23390 and (+/-)-sulpiride both blocked the increase in TFL produced by the D2-agonists. SCH23390 and (+/-)-sulpiride also blocked the increase in TFL produced by SKF 38393 in haloperidol-supersensitized animals. The antinociceptive action of intrathecally administered dopamine agonists appears to be mediated via D2-receptors. Whether the antinociception produced by SKF 38393 is exclusively contingent upon the activation of D1-receptors in the dopamine-supersensitive animal is as yet unresolved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545350      PMCID: PMC1917276          DOI: 10.1111/j.1476-5381.1987.tb16820.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

2.  Why does sulpiride not block the effect of dopamine on the dopamine-sensitive adenylate cyclase?

Authors:  G N Woodruff; S B Freedman; J A Poat
Journal:  J Pharm Pharmacol       Date:  1980-11       Impact factor: 3.765

3.  Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.

Authors:  J C Stoof; J W Kebabian
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

4.  Opposing effects of apomorphine on pain in rats. Evaluation of the dose-response curve.

Authors:  G H Paalzow; L K Paalzow
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

5.  Antinociceptive activity of opiates in the presence of the antidepressant agent nomifensine.

Authors:  J P Gonzalez; R D Sewell; P S Spencer
Journal:  Neuropharmacology       Date:  1980-07       Impact factor: 5.250

6.  Functional aspects of bulbospinal monoaminergic projections in modulating processing of somatosensory information.

Authors:  T L Yaksh; D L Hammond; G M Tyce
Journal:  Fed Proc       Date:  1981-11

7.  Stimulation of spinal dopaminergic receptors: differential effects on tail reflexes in rats.

Authors:  T S Jensen; D F Smith
Journal:  Neuropharmacology       Date:  1983-04       Impact factor: 5.250

8.  Dopaminergic effects on tail-flick response in spinal rats.

Authors:  T S Jensen; D F Smith
Journal:  Eur J Pharmacol       Date:  1982-04-08       Impact factor: 4.432

9.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Dopamine and 5-HT supersensitivity in nonorganic central pain and in morphine abstinence: fortuitous or renal analogy?

Authors:  F Sicuteri; B Anselmi; P L Del Bianco
Journal:  Adv Biochem Psychopharmacol       Date:  1980
View more
  3 in total

1.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

2.  Dopamine and pain sensitivity: neither sulpiride nor acute phenylalanine and tyrosine depletion have effects on thermal pain sensations in healthy volunteers.

Authors:  Susanne Becker; Marta Ceko; Mytsumi Louis-Foster; Nathaniel M Elfassy; Marco Leyton; Yoram Shir; Petra Schweinhardt
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

3.  Inhibition of tetrodotoxin-resistant sodium current in dorsal root ganglia neurons mediated by D1/D5 dopamine receptors.

Authors:  William Galbavy; Elham Safaie; Mario J Rebecchi; Michelino Puopolo
Journal:  Mol Pain       Date:  2013-11-28       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.